Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12606000355572
Ethics application status
Approved
Date submitted
3/08/2006
Date registered
18/08/2006
Date last updated
18/08/2006
Type of registration
Prospectively registered
Titles & IDs
Public title
Effect of barley foods on cardiovascular health biomarkers
Query!
Scientific title
A randomised cross-over study of the effects of barley foods containing beta-glucans compared with whole wheat foods on cardiovascular health biomarkers, total cholesterol, HDL cholesterol, LDL cholesterol & triglycerides in people with hypercholesterolaemia
Query!
Secondary ID [1]
295
0
Commonwealth Scientific Industrial Research Organisation (CSIRO): KR10A
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Barley
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Hypercholesterolaemia
1325
0
Query!
Condition category
Condition code
Blood
1413
1413
0
0
Query!
Other blood disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
All participants at the start of the study will be on a fat controlled diet for 2 week prior to being randomised to 1 of 2 treatments of 6 weeks duration each & crossed over at the end of each 6 weeks to the alternative. The treatments are either test foods (cereal, bread muffins) containing either barley flour or wholemeal wheat flour. There is no wash-out period between treatments.
Query!
Intervention code [1]
1220
0
Lifestyle
Query!
Comparator / control treatment
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
1934
0
Fasting lipids
Query!
Assessment method [1]
1934
0
Query!
Timepoint [1]
1934
0
At weeks 2, 8 and 14
Query!
Secondary outcome [1]
3394
0
Glucose & insulin
Query!
Assessment method [1]
3394
0
Query!
Timepoint [1]
3394
0
At weeks 2, 8 & 14
Query!
Eligibility
Key inclusion criteria
Have a fasting plasma triglyceride concentration greater than 1.7mmol/L but less than 4.0 mmol/L, and/or plasma cholesterol greater than 5.5 mmol/L.Are taking cholesterol-lowering drugs provided the dose of medication remains stable for the duration of the study.
Query!
Minimum age
30
Years
Query!
Query!
Maximum age
75
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
:Have a definite or suspected personal or family history of adverse events or hypersensitivity to barley or wheat (eg. coeliac disease)Suffer from bleeding disordersAre considered by the doctor or dietitian to be unwilling, unlikely or unable to comprehend or comply with the study protocolHave participated in another research study within 30 days preceding the commencement of this studyHave a history or presence of gastrointestinal, renal or hepatic disease of any causeAre taking any medication or food that is likely to affect the plasma cholesterol such as laxatives containing psyllium, antibiotics, probiotics or sterol-containing margarines.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Volunteers will be randomly allocated by computer generated sequence to study treatments. The treatments are coded numerically. Locked computer files indicate treatment allocation numerically and the treatment code is concealed from research staff.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Volunteers will be initially blocked matched into 2 groups based on age, body mass index and gender, cholesterol level prior to randomisation by computer generated sequence
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Crossover
Query!
Other design features
2 week run-in followed by 12 week intervention
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
21/08/2006
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
30
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
1545
0
Government body
Query!
Name [1]
1545
0
Commonwealth Scientific Industrial Research Organisation
Query!
Address [1]
1545
0
Query!
Country [1]
1545
0
Australia
Query!
Primary sponsor type
Government body
Query!
Name
Commonwealth Scientific Industrial Research Organisation, Human Nutrition
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
1358
0
None
Query!
Name [1]
1358
0
Nil
Query!
Address [1]
1358
0
Query!
Country [1]
1358
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
2975
0
CSIRO Human Nutrition
Query!
Ethics committee address [1]
2975
0
Query!
Ethics committee country [1]
2975
0
Australia
Query!
Date submitted for ethics approval [1]
2975
0
Query!
Approval date [1]
2975
0
22/06/2006
Query!
Ethics approval number [1]
2975
0
06/13
Query!
Summary
Brief summary
To discover if the consumption of foods made from CSIRO barley leads to changes in the levels of substances in the plasma (such as cholesterol) that would suggest they are beneficial for heart health.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
35242
0
Query!
Address
35242
0
Query!
Country
35242
0
Query!
Phone
35242
0
Query!
Fax
35242
0
Query!
Email
35242
0
Query!
Contact person for public queries
Name
10409
0
Anne McGuffin
Query!
Address
10409
0
CSIRO Human Nutrition
PO Box 10041
Adelaide BC SA 5000
Query!
Country
10409
0
Australia
Query!
Phone
10409
0
+61 8 83038988
Query!
Fax
10409
0
+61 8 8303 8899
Query!
Email
10409
0
[email protected]
Query!
Contact person for scientific queries
Name
1337
0
Dr David Topping
Query!
Address
1337
0
CSIRO Human Nutrition
PO Box 10041
Adelaide BC SA 5000
Query!
Country
1337
0
Australia
Query!
Phone
1337
0
+61 8 83038930
Query!
Fax
1337
0
+61 8 8303 8899
Query!
Email
1337
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF